Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France

Human Molecular Genetics

Volumn 7, Issue 2, 1998, Pages 209-216

  Soufir, Nadem ^a   Avril, Marie Françoise ^a   Chompret, Agnès ^a   Demanais, Florence ^a   Bombled, Johny ^a   Spatz, Alain ^a   Stoppa Lyonnet, Dominique ^a   Bénard, Jean ^a   Bressac de Paillerets, Brigitte ^a   Bachollet, Bertrand ^a   Boitier, Françoise ^a   Césarini, Jean Pierre ^a   Chevrant Breton, Jacqueline ^a   Couillet, Didier ^a   Courouge Dorcier, Anne Marie ^a   Desailloud, Gérard ^a   Dolfus, Arielle ^a   Garnier Fournier, Claudine ^a   Joly, Pascal ^a   Krug Milon, Monique ^a   Lantier, Karine ^a   Moureaux, Patrick ^a   Moretti, Silvia ^a   Ortoli, Jean Christophe ^a   Sassolas, Bruno ^a   Truchetet, François ^a   more..

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; PROTEIN P16;

AMINO ACID SUBSTITUTION; ARTICLE; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILIAL CANCER; FRANCE; GENE MUTATION; GENETIC PREDISPOSITION; GERM LINE; HUMAN; HUMAN CELL; MELANOMA; MUTATION RATE; PRIORITY JOURNAL;

ADULT; CHROMOSOMES, HUMAN, PAIR 9; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASES; DISEASE SUSCEPTIBILITY; EXONS; FRANCE; GENE FREQUENCY; GENES, P16; HUMANS; MELANOMA; MIDDLE AGED; PEDIGREE; PROTO-ONCOGENE PROTEINS; SKIN NEOPLASMS;

EID: 6844226190     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/7.2.209     Document Type: Article

References (60)

1. Parker,S.L., Tong,T., Bolden,S. and Wingo,P.A. (1997) Cancer statistics, 1997. CA Cancer J. Clin., 47, 5-27.
2. de Vathaire,F., Koscielny,S., Rezvani,A., Laplanche,A., Estève,J. and Ferlay,J. (1996) Estimation de l'Incidence des Cancers en France, 1983-1987. Editions INSERM, Paris, France.
3. Cawley,E.P. (1952) Genetic aspects of malignant melanoma. Arch. Dermatol., 65, 440-450.
4. Greene,M.H. and Fraumeni,J.F. (1979) The hereditary variant of familial melanoma. In Clark,W.H.,Jr, Goldman,L.I. and Mastrangelo,M.J. (eds), Human Malignant Melanoma. Grune and Stratton, New York, NY, pp. 139-166.
5. Grange,F., Chompret,A., Guilloud-Bataille,M., Guillaume,J.-C., Margulis,A., Prade,M., Demenais,F. and Avril,M.F. (1995) Comparison between familial and non familial melanoma in France. Arch. Dermatol., 131, 1154-1159.
6. Aitken,J.F., Green,A.C., MacLennan,R., Youl,P. and Martin,N.G. (1996) The Queensland familial melanoma project: study design and characteristics of participants. Melanoma Res., 6, 155-165.
7. Fountain,J.W., Karayiorgou,M., Ernstoff,M.S., Kirkwood,J.M., Vlock,D.R., Titus-Ernstoff,L., Bouchard,B., Vijayasaradhi,S., Houghton,A.N., Lahti,J., Kidd,V.J., Housman,D.E. and Dracopoli,N.C. (1992) Homozygous deletions within human chromosome band 9p21 in melanoma. Proc. Natl Acad. Sci. USA, 89, 10557-10561.
8. Petty,E.M., Gibson,L.H., Fountain,J.W., Bolognia,J.L., Yang-Feng,T.L., Housman,D.E. and Bale,A.E. (1993) Molecular definition of a chromosome 9p21 germ-line deletion in a woman with multiple melanomas and a plexiform neurofibroma: implications for 9p tumor-suppressor gene(s). Am. J. Hum. Genet., 53, 96-104.
9. Nancarrow,D.J., Mann,G.J., Holland,E., Walker,G.J., Beaton,S.C., Walters,M.K., Luxford,C., Palmer,J.M., Donald,J.A., Weber,J.L., Fountain,J.W., Kefford,R.F. and Hayward,N.K. (1993) Confirmation of chromosome 9p linkage in familial melanoma. Am. J. Hum. Genet., 53, 936-942.
10. Goldstein,A.M., Dracopoli,N.C., Engelstein,M., Fraser,M.C., Clark,W.H.,Jr and Tucker,M.A. (1994) Linkage of cutaneous malignant melanoma/ dysplastic nevi to chromosome 9p and evidence for genetic heterogeneity. Am. J. Hum. Genet., 54, 489-496.
11. Cannon-Albright,L.A., Goldgar,D.E., Meyer,L.J., Lewis,C.M., Anderson,D.E., Fountain,J.W., Hegi,M.E., Wiseman,R.W., Petty,E.M., Bale,A.E., Olopade,O.I., Diaz,M.O., Kwiatkowski,D.J., Piepkorn,M.W., Zone,J.J. and Skolnick,M.H. (1992) Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22. Science, 258, 1148-1152.
12. Serrano,M., Hannon,G.J. and Beach,D. (1993) A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature, 366, 704-707.
13. Kamb,A., Gruis,N.A., Weaver-Feldhaus,J., Liu,Q., Harshman,K., Tavtigian,S.V., Stockert,E., Day,R.S., Johnson,B.E. and Skolnick,M.H. (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science, 264, 436-440.
14. Nobori,T., Miura,K., Wu,D.J., Lois,A., Takabayashi,K. and Carson,D.A. (1994) Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature, 368, 753-756.
15. Hall,M. and Peters,G. (1996) Genetic alterations of cyclins, cyclin-dependant kinases, and CDK inhibitors in human cancers. Adv. Cancer Res., 68, 67-108.
16. INK4. Science, 267, 249-252.
17. Lukas,J., Parry,D., Aagaard,L., Mann,D.J., Bartkova,J., Strauss,M., Peters,G. and Bartek,J. (1995) Retinoblastoma-protem-dependant cell-cycle inhibition by the tumour suppressor p16. Nature, 375, 503-506.
18. Koh,J., Enders,G.H., Dynlacht,B.D. and Harlow,E. (1995) Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature, 375, 506-510.
19. ARF. Proc. Natl Acad. Sci. USA, 94, 669-673.
20. Kamb,A., Shattuck-Eidens,D., Eeles,R., Liu,Q., Gruis,N.A., Ding,W., Hussey,C., Tran,T., Miki,Y., Weaver-Feldhaus,J., McClure,M., Aitken,J.F., Anderson,D.E., Bergman,W., Frants,R., Goldar,D.E., Green,A., MacLennan,R., Martin,N.G., Meyer,L.J., Youl,P., Zone,J.J., Skolnick,M.H. and Cannon-Albright,L.A. (1994) Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nature Genet., 8, 22-26.
21. INK4a binding domain of CDK4 in familial melanoma. Nature Genet., 12, 97-99.
22. MacGeoch,C., Bishop,J.A., Bataille,V., Bishop,D.T., Frischauf,A.M., Meloni,R., Cuzik,J., Pinney,E. and Spurr,N.K. (1994) Genetic heterogeneity in familial malignant melanoma. Hum. Mol. Genet., 3, 2195-2200.
23. Hussussian,C.J., Struewing,J.P., Goldstein,A.M., Higgins,P.A.T., Ally,D.S., Steahan,M.D., Clark,W.H.,Jr, Tucker,M.A. and Dracopoli,N.C. (1994) Germline p16 mutations in familial melanoma. Nature Genet., 8, 15-21.
24. Whelan,A.J., Bartsch,D. and Goodfellow,P.J. (1995) Brief report: a familial syndrome of pancreatic cancer and melanoma with a mutation in the CDKN2 tumor-suppressor gene. N. Engl. J. Med., 333, 975-977.
25. INK4 mutations. N. Engl. J. Med., 333, 970-971.
26. INK4a allele. J. Natl Cancer Inst., 88, 1489-1491.
27. INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science. 269, 1281-1284.
28. Fitzgerald,M.G., Harkin,D.P., Silva-Arrieta,S., MacDonald,D.J., Lucchina,L.C., Unsal,H., O'Neill,E., Koh,J., Finkelstein,D.M., Isselbacher,K.J., Sober,A.J. and Haber,D.A. (1996) Prevalence of germline mutations in p16, p19ARF, and CDK4 in familial melanoma: analysis of a clinic-based population. Proc. Natl Acad. Sci. USA, 93, 8541-8545.
29. INK4 CDK inhibitory activity. Int. J. Cancer, 66, 249-254.
30. INK4b genes. Oncogenc, 11, 635-645.
31. INK4a tumor suppressor protein. Cancer Res., 55, 2503-2506.
32. Yang,R., Serrano,M., Slater,J., Leung,E. and Koeffler,H.P. (1996) Analysis of p16INK4A and its interaction with CDK4. Biochem. Biophys. Res. Commun., 218, 254-259.
33. CDKN2/INK4A. Curr. Biol., 6, 84-91.
34. Wick,S.T., Dubay,M.M., Imanil,I. and Brizuela,L. (1995) Biochemical and mutagenic analysis of the melanoma tumor suppressor gene product/p16. Oncogene, 11, 2013-2019.
35. CDKN2 associated with familial melanoma. Mol. Cell Biol., 16, 3844-3852.
36. Holland,E.A., Beaton,S.C., Becker,T.M., Grulet,O.M.C., Peters,B.A., Rizos,H., Kefford,R.F. and Mann,G.J. (1995) Analysis of the p16 gene, CDKN2, in 17 Australian melanoma kindreds. Oncogene, 11, 2289-2294.
37. INKA gene in Australian melanoma kindreds. Hum. Mol. Genet., 4, 1845-1852.
38. INK4B/MTS2 genes in biliary tract cancers. Cancer Res., 55, 2756-2760.
39. Caldas,C., Hahn,S.A., da Costa,L.T., Redston,M.S., Schutte,M., Seymour,A.B., Weinstein,C.L., Hruban,R.H., Yeo,C.J. and Kern,S.E. (1994) Frequent somatic mutations and homozygous deletions of the p16 (MTSI) gene in pancreatic adenocarcinoma. Nature Genet., 8, 27-32.
40. Naumann,M., Savitskaia,N., Eilert,C., Schramm,A., Kalthoff,H. and Schmiegel,W. (1996) Frequent codeletion of p16/MTSI and p15/MTS2 and genetic alterations in p 16/MTSI in pancreatic tumors. Gastroenterology, 110, 1215-1224.
41. Quesnel,B., Preudhomme,C., Philippe,N., Vanrumbeke,M., Dervite,I., Lai,J.-L., Bauters,F., Wattel,E. and Fenaux,P. (1995) p16 gene homozygous deletions in acute lymphoblastic leukemia. Blood, 85, 657-663.
42. Piccinin,S., Doglioni,C., Maestro,R., Vukosavljevic,T., Gasparotto,D., D'Orazi,C. and Boiocchi,M. (1997) p16/CDKN2 and CDK4 gene mutations in sporadic melanoma development and progression. Int. J. Cancer (Pred. Oncol.), 74, 26-30.
43. Pollock,P.M., Pearson,J.V and Hayward,N.K. (1996) Compilation of somatic mutations of the CDKN2 gene in human cancers: non-random distribution of base substitutions. Genes Chromosomes Cancer, 15, 77-88.
44. Platz,A., Hansson,J., Mansson-Brahme,E., Lagerlöf,B., Linder,S., Lundqvist,E., Sevigny,P., Inganäs,M. and Ringborg,U. (1997) Screening of germline mutations in the CDKN2A and CDKN2B genes in Swedish families with hereditary cutaneous melanoma. J. Natl Cancer Inst., 89, 697-702.
45. Borg,A., Johansson,U., Johansson,O., Håkansson,S., Westerdahl,J., Måsbäck,A., Olsson,H. and Ingvar,C. (1996) Novel germline p16 mutation in familial melanoma in Southern Sweden. Cancer Res., 56, 2497-2500.
46. Gruis,N.A., van der Velden,P.A., Sandkuijl,L.A., Prins,D.E., Weaver-Feldhaus,J., Kamb,A., Bergman,W. and Frants,R.R. (1995) Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds. Nature Genet., 10, 351-353.
47. INK4 function. Nature Genet., 10, 114-116.
48. Goldstein,A.M., Dracopoli,N.C., Ho,E.C., Fraser,M.C., Kearns,K.S., Bale,S.J., McBride,O.W., Clark,W.H.,Jr and Tucker,M.A. (1993) Further evidence for a locus for cutaneous malignant melanoma-dysplastic nevus (CMM/DN) on chromosome 1p, and evidence for genetic heterogeneity. Am. J. Hum. Genet., 52, 537-550.
49. Goldstein,A., Goldin,L.R., Dracopoli,N.C., Clark,W.H. and Tucker,M.A. (1996) Two-locus linkage analysis of cutaneous malignant melanoma/ dysplastic nevi. Am. J. Hum. Genet., 58, 1050-1056.
50. Gruis,N.A., Sandkuijl,L.A., van der Velden,P.A., Bergman,W. and Frants,R.R. (1995) CDKN2 explains part of the clinical phenotype in Dutch familial atypical multiple-mole melanoma (FAMMM) syndrome families. Melanoma Res., 5, 169-177.
51. ARF. Genes Chromosomes Cancer, 19, 52-54.
52. Stone,S., Dayananth,P., Jiang,P., Weaver-Feldhaus,J.M., Tavtigian,S.V., Cannon-Albright,L. and Kamb,A. (1995) Genomic structure, expression and mutational analysis of the p15 (MTS2) gene. Oncogene, 11, 987-991.
53. Quelle,D.E., Zindy,F., Ashmun,R.A. and Sherr,C.J. (1995) Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell, 83, 993-1000.
54. Flores,J.F., Walker,G.J., Glendening,J.M., Haluska,F.G., Castresana,J.S., Rubio,M.P., Pastorfide,G.C., Boyer,L.A., Kao,W.H., Bulyk,M.L., Bamhill,R.L., Hayward,N.K., Housman,D.E. and Fountain,J.W. (1996) Loss of the p16INK4a and p15INK4b genes, as well as neighboring 9p21 markers in sporadic melanoma. Cancer Res., 56, 5023-5032.
55. Merlo,A., Herman,J.G., Mao,L., Lee,D.J., Gabrielson,E., Burger,P.C., Baylin,S.B. and Sidransky,D. (1995) 5′ CpG island melhylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTSI in human cancers. Nature Med., 1, 686-692.
56. Little,M. and Wainwright,B. (1995) Methylation and p16: suppressing the suppressor. Nature Med., 1, 633-634.
57. Bergman,W., Watson,P., de Jong,J., Lynch,H.T. and Fusaro,R.M. (1990) Systemic cancer and the FAMMM syndrome. Br. J. Cancer, 61, 932-936.
58. Lazar,V., Grandjouan,S., Bognel,C., Couturier,D., Rougier,P., Bellet,D. and Bressac-de Paillerets,B. (1994) Accumulation of multiple mutations in tumour suppressor genes during colorectal tumorigenesis in HNPCC patients. Ham. Mol. Genet., 3, 2257-2260.
59. Lazar,V., Hazard,F., Bertin,F., Janin,N., Bellet,D. and Bressac,B. (1993) Simple sequence repeat polymorphism within the p53 gene. Oncogene, 8, 1703-1705.
60. INK4B is a potential effector of TGF-b-induced cell cycle arrest. Nature, 371, 257-261.